Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

340 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Elevated Myl9 reflects the Myl9-containing microthrombi in SARS-CoV-2-induced lung exudative vasculitis and predicts COVID-19 severity.
Iwamura C, Hirahara K, Kiuchi M, Ikehara S, Azuma K, Shimada T, Kuriyama S, Ohki S, Yamamoto E, Inaba Y, Shiko Y, Aoki A, Kokubo K, Hirasawa R, Hishiya T, Tsuji K, Nagaoka T, Ishikawa S, Kojima A, Mito H, Hase R, Kasahara Y, Kuriyama N, Tsukamoto T, Nakamura S, Urushibara T, Kaneda S, Sakao S, Tobiume M, Suzuki Y, Tsujiwaki M, Kubo T, Hasegawa T, Nakase H, Nishida O, Takahashi K, Baba K, Iizumi Y, Okazaki T, Kimura MY, Yoshino I, Igari H, Nakajima H, Suzuki T, Hanaoka H, Nakada TA, Ikehara Y, Yokote K, Nakayama T. Iwamura C, et al. Among authors: hanaoka h. Proc Natl Acad Sci U S A. 2022 Aug 16;119(33):e2203437119. doi: 10.1073/pnas.2203437119. Epub 2022 Jul 27. Proc Natl Acad Sci U S A. 2022. PMID: 35895716 Free PMC article.
Antibody responses to BNT162b2 mRNA COVID-19 vaccine and their predictors among healthcare workers in a tertiary referral hospital in Japan.
Kageyama T, Ikeda K, Tanaka S, Taniguchi T, Igari H, Onouchi Y, Kaneda A, Matsushita K, Hanaoka H, Nakada TA, Ohtori S, Yoshino I, Matsubara H, Nakayama T, Yokote K, Nakajima H. Kageyama T, et al. Among authors: hanaoka h. Clin Microbiol Infect. 2021 Dec;27(12):1861.e1-1861.e5. doi: 10.1016/j.cmi.2021.07.042. Epub 2021 Aug 8. Clin Microbiol Infect. 2021. PMID: 34375755 Free PMC article.
Detecting time-evolving phenotypic components of adverse reactions against BNT162b2 SARS-CoV-2 vaccine via non-negative tensor factorization.
Ikeda K, Nakada TA, Kageyama T, Tanaka S, Yoshida N, Ishikawa T, Goshima Y, Otaki N, Iwami S, Shimamura T, Taniguchi T, Igari H, Hanaoka H, Yokote K, Tsuyuzaki K, Nakajima H, Kawakami E. Ikeda K, et al. Among authors: hanaoka h. iScience. 2022 Oct 21;25(10):105237. doi: 10.1016/j.isci.2022.105237. Epub 2022 Sep 28. iScience. 2022. PMID: 36188188 Free PMC article.
Phase II study of α-galactosylceramide-pulsed antigen-presenting cells in patients with advanced or recurrent non-small cell lung cancer.
Toyoda T, Kamata T, Tanaka K, Ihara F, Takami M, Suzuki H, Nakajima T, Ikeuchi T, Kawasaki Y, Hanaoka H, Nakayama T, Yoshino I, Motohashi S. Toyoda T, et al. Among authors: hanaoka h. J Immunother Cancer. 2020 Mar;8(1):e000316. doi: 10.1136/jitc-2019-000316. J Immunother Cancer. 2020. PMID: 32188702 Free PMC article. Clinical Trial.
A phase I-II study of alpha-galactosylceramide-pulsed IL-2/GM-CSF-cultured peripheral blood mononuclear cells in patients with advanced and recurrent non-small cell lung cancer.
Motohashi S, Nagato K, Kunii N, Yamamoto H, Yamasaki K, Okita K, Hanaoka H, Shimizu N, Suzuki M, Yoshino I, Taniguchi M, Fujisawa T, Nakayama T. Motohashi S, et al. Among authors: hanaoka h. J Immunol. 2009 Feb 15;182(4):2492-501. doi: 10.4049/jimmunol.0800126. J Immunol. 2009. PMID: 19201905 Clinical Trial.
LCAT-trial-24 weeks: Protocol for a clinical study to evaluate the safety of regenerative medicine and gene therapy by the autologous transplantation of human lecithin:cholesterol acyltransferase gene-transduced human pre-adipocytes.
Kuroda M, Hori M, Maezawa Y, Kubota Y, Mitsukawa N, Shiko Y, Ozawa Y, Kawasaki Y, Saito Y, Hanaoka H, Yokote K. Kuroda M, et al. Among authors: hanaoka h. Contemp Clin Trials Commun. 2022 Jun 9;28:100946. doi: 10.1016/j.conctc.2022.100946. eCollection 2022 Aug. Contemp Clin Trials Commun. 2022. PMID: 35734220 Free PMC article.
Accumulation of activated invariant natural killer T cells in the tumor microenvironment after α-galactosylceramide-pulsed antigen presenting cells.
Nagato K, Motohashi S, Ishibashi F, Okita K, Yamasaki K, Moriya Y, Hoshino H, Yoshida S, Hanaoka H, Fujii S, Taniguchi M, Yoshino I, Nakayama T. Nagato K, et al. Among authors: hanaoka h. J Clin Immunol. 2012 Oct;32(5):1071-81. doi: 10.1007/s10875-012-9697-9. Epub 2012 Apr 26. J Clin Immunol. 2012. PMID: 22534863 Clinical Trial.
Evaluating the efficacy and safety of transdermal electrical stimulation on the visual functions of patients with retinitis pigmentosa: a clinical trial protocol for a prospective, multicentre, randomised, double-masked and sham-controlled design (ePICO trial).
Miura G, Ozawa Y, Shiko Y, Kawasaki Y, Iwase T, Fujiwara T, Baba T, Hanaoka H, Yamamoto S. Miura G, et al. Among authors: hanaoka h. BMJ Open. 2022 May 6;12(5):e057193. doi: 10.1136/bmjopen-2021-057193. BMJ Open. 2022. PMID: 35523495 Free PMC article.
340 results